Bleomycin is a Intramuscular; Intrapleural; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Bleomycin Sulfate.
Product ID | 0409-0323_4942d4a5-d2e7-4fdb-8a66-512f3eae7969 |
NDC | 0409-0323 |
Product Type | Human Prescription Drug |
Proprietary Name | Bleomycin |
Generic Name | Bleomycin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2018-04-25 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065031 |
Labeler Name | Hospira, Inc. |
Substance Name | BLEOMYCIN SULFATE |
Active Ingredient Strength | 30 [USP'U]/1 |
Pharm Classes | Cytoprotective Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-04-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA065031 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-25 |
Ingredient | Strength |
---|---|
BLEOMYCIN SULFATE | 30 [USP'U]/1 |
SPL SET ID: | e629ba5a-4e08-4249-9551-af6dbd98a7e4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9240 | Bleomycin | Bleomycin |
0143-9241 | Bleomycin | Bleomycin |
0409-0323 | Bleomycin | BLEOMYCIN |
0409-0332 | Bleomycin | BLEOMYCIN |
0703-3154 | Bleomycin | Bleomycin |
0703-3155 | Bleomycin | Bleomycin |
16714-886 | Bleomycin | Bleomycin |
16714-908 | Bleomycin | Bleomycin |
61703-323 | Bleomycin | BLEOMYCIN |
61703-332 | Bleomycin | BLEOMYCIN |
63323-136 | Bleomycin | BLEOMYCIN SULFATE |
63323-137 | Bleomycin | BLEOMYCIN SULFATE |
69097-364 | Bleomycin | Bleomycin |
70121-1567 | Bleomycin | Bleomycin |
71288-106 | Bleomycin | Bleomycin Sulfate |
71288-107 | Bleomycin | Bleomycin Sulfate |